Received Apr 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | TF27T | IM / RA |
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | A2JX7 | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8271AC | IM / RA |
On 12/16/2024, Pt was to receive Meningococcal conjugate quadrivalent (MenACWY-TT) as part of routine vaccinations. However, Meningococcal B (Bexsero) vaccine was given in place of MenACWY-TT vaccine in error. Upon realizing error, clinic nurse informed nurse supervisor. Pt's guardian/parent was informed of the error and need to administer correct Meningococcal vaccine (MenACWY-TT) discussed. Pt's mother verbalized understanding. Pt was then given correct Meningococcal (MenACWY-TT) vaccine. Pt had no adverse reaction to vaccines given, VAERS report being completed due to recommendation from CDC regarding immunization error.
None
None
None
None
None